A 64 week study, phase three, randomised, double-masked, active-controlled study of the Efficacy and Safety of Aflibercept 8mg in Macular Edema Secondary to Retinal Vein Occlusion.
ClinicalTrials.gov Identifier: NCT05850520
Principal Investigator: Professor Ian McAllister
For further information about this study, you may visit Clinical Trial Registry: https://clinicaltrials.gov/study/NCT05850520.
You can alternatively contact the Lions Eye Institute Clinical Trials Office telephone (08) 9381 0750 or email lionsvisiontrials@lei.org.au.
